MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
UPDATE: MiMedx Group (MDXG) Reports Q3 EPS of $0.08, Offers Q4 Guidance
October 26, 2017 2:01 PM EDT(Updated - October 26, 2017 2:04 PM EDT)
MiMedx Group (NASDAQ: MDXG) reported Q3 EPS of $0.08, versus $0.06 reported last year. Revenue for the quarter came in at $84.6 million, versus $64.43 million reported last year.
Fourth Quarter and Full Year 2017 Guidance HighlightsMiMedx provided its revenue... More
